236 related articles for article (PubMed ID: 9811707)
1. Study of Dengue virus infection in SCID mice engrafted with human K562 cells.
Lin YL; Liao CL; Chen LK; Yeh CT; Liu CI; Ma SH; Huang YY; Huang YL; Kao CL; King CC
J Virol; 1998 Dec; 72(12):9729-37. PubMed ID: 9811707
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection.
Wu SJ; Hayes CG; Dubois DR; Windheuser MG; Kang YH; Watts DM; Sieckmann DG
Am J Trop Med Hyg; 1995 May; 52(5):468-76. PubMed ID: 7771614
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel mouse model for dengue virus infection.
An J; Kimura-Kuroda J; Hirabayashi Y; Yasui K
Virology; 1999 Oct; 263(1):70-7. PubMed ID: 10544083
[TBL] [Abstract][Full Text] [Related]
4. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2.
Blaney JE; Hanson CT; Hanley KA; Murphy BR; Whitehead SS
BMC Infect Dis; 2004 Oct; 4():39. PubMed ID: 15461822
[TBL] [Abstract][Full Text] [Related]
5. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.
Vaughn DW; Green S; Kalayanarooj S; Innis BL; Nimmannitya S; Suntayakorn S; Endy TP; Raengsakulrach B; Rothman AL; Ennis FA; Nisalak A
J Infect Dis; 2000 Jan; 181(1):2-9. PubMed ID: 10608744
[TBL] [Abstract][Full Text] [Related]
6. Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.
Blaney JE; Matro JM; Murphy BR; Whitehead SS
J Virol; 2005 May; 79(9):5516-28. PubMed ID: 15827166
[TBL] [Abstract][Full Text] [Related]
7. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice.
Kuruvilla JG; Troyer RM; Devi S; Akkina R
Virology; 2007 Dec; 369(1):143-52. PubMed ID: 17707071
[TBL] [Abstract][Full Text] [Related]
8. Humanized mice show clinical signs of dengue fever according to infecting virus genotype.
Mota J; Rico-Hesse R
J Virol; 2009 Sep; 83(17):8638-45. PubMed ID: 19535452
[TBL] [Abstract][Full Text] [Related]
9. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical.
Shresta S; Kyle JL; Snider HM; Basavapatna M; Beatty PR; Harris E
J Virol; 2004 Mar; 78(6):2701-10. PubMed ID: 14990690
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis in the mouse central nervous system in response to infection with mouse-neurovirulent dengue viruses.
Desprès P; Frenkiel MP; Ceccaldi PE; Duarte Dos Santos C; Deubel V
J Virol; 1998 Jan; 72(1):823-9. PubMed ID: 9420294
[TBL] [Abstract][Full Text] [Related]
11. Dengue-specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection.
An J; Zhou DS; Zhang JL; Morida H; Wang JL; Yasui K
Immunol Lett; 2004 Sep; 95(2):167-74. PubMed ID: 15388257
[TBL] [Abstract][Full Text] [Related]
12. Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection.
Wang M; Yang F; Huang D; Huang Y; Zhang X; Wang C; Zhang S; Zhang R
Front Cell Infect Microbiol; 2017; 7():157. PubMed ID: 28536674
[TBL] [Abstract][Full Text] [Related]
13. Bispecific monoclonal antibodies mediate binding of dengue virus to erythrocytes in a monkey model of passive viremia.
Hahn CS; French OG; Foley P; Martin EN; Taylor RP
J Immunol; 2001 Jan; 166(2):1057-65. PubMed ID: 11145685
[TBL] [Abstract][Full Text] [Related]
14. Murine model for dengue virus-induced lethal disease with increased vascular permeability.
Shresta S; Sharar KL; Prigozhin DM; Beatty PR; Harris E
J Virol; 2006 Oct; 80(20):10208-17. PubMed ID: 17005698
[TBL] [Abstract][Full Text] [Related]
15. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever.
Yeh WT; Chen RF; Wang L; Liu JW; Shaio MF; Yang KD
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):84-90. PubMed ID: 16965355
[TBL] [Abstract][Full Text] [Related]
16. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
[TBL] [Abstract][Full Text] [Related]
17. Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys.
Kochel TJ; Watts DM; Gozalo AS; Ewing DF; Porter KR; Russell KL
J Infect Dis; 2005 Mar; 191(6):1000-4. PubMed ID: 15717278
[TBL] [Abstract][Full Text] [Related]
18. Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection.
Xu M; Züst R; Toh YX; Pfaff JM; Kahle KM; Davidson E; Doranz BJ; Velumani S; Tukijan F; Wang CI; Fink K
J Virol; 2016 Dec; 90(24):11122-11131. PubMed ID: 27707930
[TBL] [Abstract][Full Text] [Related]
19. Dengue Virus-Infected Dendritic Cells, but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules.
Costa VV; Ye W; Chen Q; Teixeira MM; Preiser P; Ooi EE; Chen J
mBio; 2017 Aug; 8(4):. PubMed ID: 28765218
[TBL] [Abstract][Full Text] [Related]
20. Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.
Messer WB; de Alwis R; Yount BL; Royal SR; Huynh JP; Smith SA; Crowe JE; Doranz BJ; Kahle KM; Pfaff JM; White LJ; Sariol CA; de Silva AM; Baric RS
Proc Natl Acad Sci U S A; 2014 Feb; 111(5):1939-44. PubMed ID: 24385585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
